Mohannad Emad Qazzaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mohannad Emad Qazzaz has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Fawaz A. Alassaf
Department of Pharmacology and Toxicology, College of Pharmacy, University of Mosul, Mosul, Nineveh Governorate 41002, Iraq
4 shared publications - Mohammed Najim Abed
Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, Iraq
4 shared publications - Kuan-Hon Lim
School of Pharmacy, University of Nottingham Malaysia, Semenyih, Malaysia
3 shared publications Tracey D. Bradshaw
School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK
3 shared publicationsMohanad Alfahad
University of Mosul, College of Pharmacy, University of Mosul , Iraq
2 shared publications- Mohanad Alfahad
Department of Pharmaceutics College of Pharmacy, University of Mosul, Mosul, Iraq
2 shared publications
Latest Publications
- Open Access
- 31 May 2024
- Published by Korean Society for Bone and Mineral Research in Journal of Bone Metabolism
- Vol. 31 (2) , 75-89
Exploring the Interplay between Vitamin D, Insulin Resistance, Obesity and Skeletal Health
Vitamin D (ViD), plays an important role in calcium absorption and bone mineralization, is associated with bone mineral density. Severe deficiency in ViD has long been linked to conditions such as rickets in children and osteomalacia in adults, revealing its substantial role in skeletal health. Additionally, investigations show an existing interconnection between ViD and insulin resistance (Ins-R), especially in patients with type 2 diabetes mellitus (T2DM). Obesity, in conjunction with Ins-R, may augment the risk of osteoporosis and deterioration of skeletal health. This review aims to examine recent studies on the interplay between ViD, Ins-R, obesity, and their impact on skeletal health, to offer insights into potential therapeutic strategies. Cochrane Library, Google Scholar, and Pubmed were searched to investigate relevant studies until December 2023. Current research demonstrates ViD’s impact on pancreatic β-cell function, systemic inflammation, and insulin action regulation. Our findings highlight an intricate association between ViD, Ins-R, obesity, and skeletal health, providing a perspective for the prevention and/or treatment of skeletal disorders in patients with obesity, Ins-R, and T2DM.
- 31 May 2024
- Published by Korean Society for Bone and Mineral Research in Journal of Bone Metabolism
- Vol. 31 (2) , 75-89
Open AccessExploring the Interplay between Vitamin D, Insulin Resistance, Obesity and Skeletal Health
Vitamin D (ViD), plays an important role in calcium absorption and bone mineralization, is associated with bone mineral density. Severe deficiency in ViD has long been linked to conditions such as rickets in children and osteomalacia in adults, revealing its substantial role in skeletal health. Additionally, investigations show an existing interconnection between ViD and insulin resistance (Ins-R), especially in patients with type 2 diabetes mellitus (T2DM). Obesity, in conjunction with Ins-R, may augment the risk of osteoporosis and deterioration of skeletal health. This review aims to examine recent studies on the interplay between ViD, Ins-R, obesity, and their impact on skeletal health, to offer insights into potential therapeutic strategies. Cochrane Library, Google Scholar, and Pubmed were searched to investigate relevant studies until December 2023. Current research demonstrates ViD’s impact on pancreatic β-cell function, systemic inflammation, and insulin action regulation. Our findings highlight an intricate association between ViD, Ins-R, obesity, and skeletal health, providing a perspective for the prevention and/or treatment of skeletal disorders in patients with obesity, Ins-R, and T2DM.
- Open Access
- 15 February 2024
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 14 (2) , 222-232
Solid dispersion: application and limitations
Solubility and dissolution rate are essential factors in the bioavailability of a drug. The drug must be well-soluble in water to have good bioavailability. Solid dispersion is among the most widely used and effective methods for increasing solubility and releasing inadequately water-soluble medications. Solid dispersion requires the choice of a suitable carrier for the right active pharmaceutical ingredients and the proper techniques for preparing solid dispersions. The reliable dispersion system is designed in various ways to achieve the goal and avoid the accompanying obstacles. Keywords: solid dispersion, solubility, solvent evaporation, lyophilization, generation, methods
- 15 February 2024
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 14 (2) , 222-232
Open AccessSolid dispersion: application and limitations
Solubility and dissolution rate are essential factors in the bioavailability of a drug. The drug must be well-soluble in water to have good bioavailability. Solid dispersion is among the most widely used and effective methods for increasing solubility and releasing inadequately water-soluble medications. Solid dispersion requires the choice of a suitable carrier for the right active pharmaceutical ingredients and the proper techniques for preparing solid dispersions. The reliable dispersion system is designed in various ways to achieve the goal and avoid the accompanying obstacles. Keywords: solid dispersion, solubility, solvent evaporation, lyophilization, generation, methods
- Open Access
- 12 February 2024
- Published by Institute of Nephrology of the National Academy of Medical Sciences in Ukrainian Journal of Nephrology and Dialysis
- No. 2(82),p. 25-33
Investigating the nephrotoxic effects of medroxyprogesterone in female albino rats
Progestins, though integral to various bodily functions as endogenous hormones, have been associated with adverse effects when administered exogenously in excessive amounts. This study investigates the impact of medroxyprogesterone (MePro) on kidney function, examining biochemical parameters, histology, and oxidative stress markers. Methods. Twenty healthy adult female Albino rats were assigned to four groups: Group 1 consisted of 10 rats before MePro treatment, Group 2 comprised the same rats 8 weeks after intramuscular MePro administration (3.5 mg/week), Group 3 served as the control group, and Group 4 represented the same rats as Group 3 at the conclusion of the study. Serological and histological markers of renal damage, as well as parameters of oxidative stress (malondialdehyde, MDA) and antioxidant status (total antioxidant status, TAS), were investigated in female albino rats following MePro administration. Results. MePro administration resulted in notable increases in weight, urea, creatinine, and MDA levels, alongside a decrease in TAS compared to baseline levels (p < 0.001). Conversely, the control groups showed no significant changes in these parameters over time. Creatinine levels and oxidative stress markers in Group 2 were notably higher than those in Groups 3 and 4 (p < 0.001). Post-MePro administration, renal histopathology revealed significant deposition of hyaline casts in the tubular lumens, along with vascular lesions, hemorrhage, and inflammation. Conclusions. The decline in kidney function, antioxidant status, and propensity for renal injury associated with MePro use underscore its potential renal toxicity.
- 12 February 2024
- Published by Institute of Nephrology of the National Academy of Medical Sciences in Ukrainian Journal of Nephrology and Dialysis
- No. 2(82),p. 25-33
Open AccessInvestigating the nephrotoxic effects of medroxyprogesterone in female albino rats
Progestins, though integral to various bodily functions as endogenous hormones, have been associated with adverse effects when administered exogenously in excessive amounts. This study investigates the impact of medroxyprogesterone (MePro) on kidney function, examining biochemical parameters, histology, and oxidative stress markers. Methods. Twenty healthy adult female Albino rats were assigned to four groups: Group 1 consisted of 10 rats before MePro treatment, Group 2 comprised the same rats 8 weeks after intramuscular MePro administration (3.5 mg/week), Group 3 served as the control group, and Group 4 represented the same rats as Group 3 at the conclusion of the study. Serological and histological markers of renal damage, as well as parameters of oxidative stress (malondialdehyde, MDA) and antioxidant status (total antioxidant status, TAS), were investigated in female albino rats following MePro administration. Results. MePro administration resulted in notable increases in weight, urea, creatinine, and MDA levels, alongside a decrease in TAS compared to baseline levels (p < 0.001). Conversely, the control groups showed no significant changes in these parameters over time. Creatinine levels and oxidative stress markers in Group 2 were notably higher than those in Groups 3 and 4 (p < 0.001). Post-MePro administration, renal histopathology revealed significant deposition of hyaline casts in the tubular lumens, along with vascular lesions, hemorrhage, and inflammation. Conclusions. The decline in kidney function, antioxidant status, and propensity for renal injury associated with MePro use underscore its potential renal toxicity.
- Open Access
- 1 December 2021
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 34 (4) , 192-200
Insights into the perspective correlation between vitamin D and regulation of hormones: sex hormones and prolactin
Aim. Vitamin D is currently an exciting research target, besides its obvious role in calcium homeostasis and bone health, enormous work is being directed at examining the effects of this vitamin on various biological functions and pathological conditions. Material and methods. The review of the literature and the analysis took about six months and was carried out through PubMed. This is a search engine opening mainly the MEDLINE database of trusted references. We called up all studies written in English that were published between the years 2004 to 2021 and that came through using the applied search terms, and analysed all those that met the criteria. Results. The endocrine system with its many glands and hormones and their essential roles in the maintenance of normal body functioning cannot be far from interactions with vitamin D. Male and female sex hormones are no exceptions and many studies have investigated the correlations between these hormones and vitamin D. As such, direct and indirect relationships have been found between vitamin D, its receptors or one of its metabolising enzymes with sex hormones and the development of reproductive organs in males and females. Conclusion. This review summarises the research investigating the associations of vitamin D with sex hormones and reproductive organs in males and females, and thus may pave the road for future studies that will investigate the clinical significance of vitamin D in the management of reproductive system disorders. Despite some conflicting results about the relationship between VD and the effectiveness of the reproductive system, many studies confirm the presence of receptors for this vitamin in the reproductive system, and this supports the direct or indirect relationship between VD and prolactin or VD and testosterone through PO4 and Ca2+ homeostasis, or production of osteocalcin. Therefore, VD is positively associated with semen quality and androgen status. Furthermore, a direct relationship between VD and the production of progesterone, estrogen and estrone in human ovarian cells has been supported by many studies.
- 1 December 2021
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 34 (4) , 192-200
Open AccessInsights into the perspective correlation between vitamin D and regulation of hormones: sex hormones and prolactin
Aim. Vitamin D is currently an exciting research target, besides its obvious role in calcium homeostasis and bone health, enormous work is being directed at examining the effects of this vitamin on various biological functions and pathological conditions. Material and methods. The review of the literature and the analysis took about six months and was carried out through PubMed. This is a search engine opening mainly the MEDLINE database of trusted references. We called up all studies written in English that were published between the years 2004 to 2021 and that came through using the applied search terms, and analysed all those that met the criteria. Results. The endocrine system with its many glands and hormones and their essential roles in the maintenance of normal body functioning cannot be far from interactions with vitamin D. Male and female sex hormones are no exceptions and many studies have investigated the correlations between these hormones and vitamin D. As such, direct and indirect relationships have been found between vitamin D, its receptors or one of its metabolising enzymes with sex hormones and the development of reproductive organs in males and females. Conclusion. This review summarises the research investigating the associations of vitamin D with sex hormones and reproductive organs in males and females, and thus may pave the road for future studies that will investigate the clinical significance of vitamin D in the management of reproductive system disorders. Despite some conflicting results about the relationship between VD and the effectiveness of the reproductive system, many studies confirm the presence of receptors for this vitamin in the reproductive system, and this supports the direct or indirect relationship between VD and prolactin or VD and testosterone through PO4 and Ca2+ homeostasis, or production of osteocalcin. Therefore, VD is positively associated with semen quality and androgen status. Furthermore, a direct relationship between VD and the production of progesterone, estrogen and estrone in human ovarian cells has been supported by many studies.
- Open Access
- 15 August 2021
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 11 (4-S) , 242-246
Proton pump inhibitors and peptic ulcer management: Antioxidant mechanisms
Peptic ulcer (P.U.) is the gastrointestinal tract's most frequent disorder affecting mainly the stomach and duodenum. Surgical intervention, ingested materials and microbial infections may trigger inflammation that further predispose to oxidative stress. Proton pump inhibitors (PPIs) are group of compounds established for suppressions of gastric acid secretions profoundly and permanently over a reasonably long period of time. Oxidative stress has been shown to be involved in the pathophysiology of various diseases and disorders, including P.U. Particularly when H. pylori infection accompanies it. In addition to the colonization of this microorganism, gastric mucosa may be subjected to extreme oxidative stress with large levels of inflammatory cell aggregation, which may eventually predispose to the disorder. PPIs exert several effects other than gastric acid suppression that can be used to treat Helicobacter pylori infections, disorders of the respiratory tract, viral infections, and other conditions related to dysfunction of endothelium by activating endogenous antioxidant protection and reducing the release of cytokine. Recent therapeutic protocols have recommended PPIs as gastro-protective compounds not only because of their acid suppression properties, but also because of their potent antioxidant and anti-inflammatory properties. Keywords: Proton Pump Inhibitors, Peptic Ulcer, Oxidative Stress, H. pylori
- 15 August 2021
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 11 (4-S) , 242-246
Open AccessProton pump inhibitors and peptic ulcer management: Antioxidant mechanisms
Peptic ulcer (P.U.) is the gastrointestinal tract's most frequent disorder affecting mainly the stomach and duodenum. Surgical intervention, ingested materials and microbial infections may trigger inflammation that further predispose to oxidative stress. Proton pump inhibitors (PPIs) are group of compounds established for suppressions of gastric acid secretions profoundly and permanently over a reasonably long period of time. Oxidative stress has been shown to be involved in the pathophysiology of various diseases and disorders, including P.U. Particularly when H. pylori infection accompanies it. In addition to the colonization of this microorganism, gastric mucosa may be subjected to extreme oxidative stress with large levels of inflammatory cell aggregation, which may eventually predispose to the disorder. PPIs exert several effects other than gastric acid suppression that can be used to treat Helicobacter pylori infections, disorders of the respiratory tract, viral infections, and other conditions related to dysfunction of endothelium by activating endogenous antioxidant protection and reducing the release of cytokine. Recent therapeutic protocols have recommended PPIs as gastro-protective compounds not only because of their acid suppression properties, but also because of their potent antioxidant and anti-inflammatory properties. Keywords: Proton Pump Inhibitors, Peptic Ulcer, Oxidative Stress, H. pylori
- 14 April 2020
- Published by S. Karger AG in Pharmacology
- Vol. 105 (11-12) , 645-651
Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole
Introduction: Peptic lesions usually develop when there is an imbalance between aggressive drivers and gastro-protective mediators that guard the lining of the gastrointestinal tract. The most crucial of these mediators are antioxidants, whose loss may predispose to oxidative stress, which is believed to be the main aggravator of several diseases including peptic ulcer. Proton pump inhibitors (PPIs) are drugs that are highly effective and widely used for therapeutic management of peptic disorders through inhibition of gastric acid secretion. In spite of this, oxidative damage may continue to be a major issue that can predispose to future lesions. Objective: The present study is designed to explore the possible antioxidant capability of different PPIs, including omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole, in an aim to suggest an agent that, in addition to its acid-suppression properties, can provide antioxidant profit. Methods: The antioxidant activity of different PPIs was evaluated calorimetrically to test the ability of each drug to quench oxygen free radical, using the well-known stable free radical α,α-diphenyl-β-picrylhydrazyl (DPPH), and compared to ascorbic acid (AA; vitamin C). The measurements were performed using a spectrophotometer at 517 nm. Results: All the studied drugs reduced DPPH, but to different extents. However, omeprazole and esomeprazole showed the highest ability to scavenge free radicals (50% inhibitory concentrations [IC50s] of the percentage for free radical scavenging activity are 18.7 ± 5.7 and 18.7 ± 5.7, respectively, and the AA equivalents are 83,772 ± 11,887 and 81,732 ± 8,523 mg AA/100 g, respectively). Conversely, lansoprazole, pantoprazole, and rabeprazole might be having no role in this story (IC50s of the percentage for free radical scavenging activity are 49.3 ± 3.1, 49 ± 9.4, and 40.7 ± 7.2, respectively, and the AA equivalents are 30,458 ± 3,884, 32,222 ± 10,377, and 37,876 ± 8,816 mg AA/100 g, respectively). Conclusion: Thus, omeprazole and esomeprazole may confer a significant dual action in gastrointestinal protection by providing potent antioxidant properties in addition to their major role as acid-suppression agents. However, further studies are essential to elucidate the mechanism behind the difference between the drugs of the same class.
- 14 April 2020
- Published by S. Karger AG in Pharmacology
- Vol. 105 (11-12) , 645-651
Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole
Introduction: Peptic lesions usually develop when there is an imbalance between aggressive drivers and gastro-protective mediators that guard the lining of the gastrointestinal tract. The most crucial of these mediators are antioxidants, whose loss may predispose to oxidative stress, which is believed to be the main aggravator of several diseases including peptic ulcer. Proton pump inhibitors (PPIs) are drugs that are highly effective and widely used for therapeutic management of peptic disorders through inhibition of gastric acid secretion. In spite of this, oxidative damage may continue to be a major issue that can predispose to future lesions. Objective: The present study is designed to explore the possible antioxidant capability of different PPIs, including omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole, in an aim to suggest an agent that, in addition to its acid-suppression properties, can provide antioxidant profit. Methods: The antioxidant activity of different PPIs was evaluated calorimetrically to test the ability of each drug to quench oxygen free radical, using the well-known stable free radical α,α-diphenyl-β-picrylhydrazyl (DPPH), and compared to ascorbic acid (AA; vitamin C). The measurements were performed using a spectrophotometer at 517 nm. Results: All the studied drugs reduced DPPH, but to different extents. However, omeprazole and esomeprazole showed the highest ability to scavenge free radicals (50% inhibitory concentrations [IC50s] of the percentage for free radical scavenging activity are 18.7 ± 5.7 and 18.7 ± 5.7, respectively, and the AA equivalents are 83,772 ± 11,887 and 81,732 ± 8,523 mg AA/100 g, respectively). Conversely, lansoprazole, pantoprazole, and rabeprazole might be having no role in this story (IC50s of the percentage for free radical scavenging activity are 49.3 ± 3.1, 49 ± 9.4, and 40.7 ± 7.2, respectively, and the AA equivalents are 30,458 ± 3,884, 32,222 ± 10,377, and 37,876 ± 8,816 mg AA/100 g, respectively). Conclusion: Thus, omeprazole and esomeprazole may confer a significant dual action in gastrointestinal protection by providing potent antioxidant properties in addition to their major role as acid-suppression agents. However, further studies are essential to elucidate the mechanism behind the difference between the drugs of the same class.
- Open Access
- 13 July 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-7
Sustainable Syntheses of (−)-Jerantinines A & E and Structural Characterisation of the Jerantinine-Tubulin Complex at the Colchicine Binding Site
The jerantinine family of Aspidosperma indole alkaloids from Tabernaemontana corymbosa are potent microtubule-targeting agents with broad spectrum anticancer activity. The natural supply of these precious metabolites has been significantly disrupted due to the inclusion of T. corymbosa on the endangered list of threatened species by the International Union for Conservation of Nature. This report describes the asymmetric syntheses of (−)-jerantinines A and E from sustainably sourced (−)-tabersonine, using a straight-forward and robust biomimetic approach. Biological investigations of synthetic (−)-jerantinine A, along with molecular modelling and X-ray crystallography studies of the tubulin—(−)-jerantinine B acetate complex, advocate an anticancer mode of action of the jerantinines operating via microtubule disruption resulting from binding at the colchicine site. This work lays the foundation for accessing useful quantities of enantiomerically pure jerantinine alkaloids for future development.
- 13 July 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-7
Open AccessSustainable Syntheses of (−)-Jerantinines A & E and Structural Characterisation of the Jerantinine-Tubulin Complex at the Colchicine Binding Site
The jerantinine family of Aspidosperma indole alkaloids from Tabernaemontana corymbosa are potent microtubule-targeting agents with broad spectrum anticancer activity. The natural supply of these precious metabolites has been significantly disrupted due to the inclusion of T. corymbosa on the endangered list of threatened species by the International Union for Conservation of Nature. This report describes the asymmetric syntheses of (−)-jerantinines A and E from sustainably sourced (−)-tabersonine, using a straight-forward and robust biomimetic approach. Biological investigations of synthetic (−)-jerantinine A, along with molecular modelling and X-ray crystallography studies of the tubulin—(−)-jerantinine B acetate complex, advocate an anticancer mode of action of the jerantinines operating via microtubule disruption resulting from binding at the colchicine site. This work lays the foundation for accessing useful quantities of enantiomerically pure jerantinine alkaloids for future development.
- 1 March 2018
- Published by Elsevier in Fitoterapia
- Vol. 125, 161-173
Discovery of a highly active anticancer analogue of cardamonin that acts as an inducer of caspase-dependent apoptosis and modulator of the mTOR pathway
- 1 March 2018
- Published by Elsevier in Fitoterapia
- Vol. 125, 161-173
Discovery of a highly active anticancer analogue of cardamonin that acts as an inducer of caspase-dependent apoptosis and modulator of the mTOR pathway
- 1 March 2016
- Published by Elsevier in Phytochemistry Letters
- Vol. 15, 136-141
Fistulopsines A and B antiproliferative septicine-type alkaloids from Ficus fistulosa
- 1 March 2016
- Published by Elsevier in Phytochemistry Letters
- Vol. 15, 136-141
Fistulopsines A and B antiproliferative septicine-type alkaloids from Ficus fistulosa
- 1 January 2016
- Published by Elsevier in Cancer Letters
- Vol. 370 (2) , 185-197
In vitro anticancer properties and biological evaluation of novel natural alkaloid jerantinine B
- 1 January 2016
- Published by Elsevier in Cancer Letters
- Vol. 370 (2) , 185-197
In vitro anticancer properties and biological evaluation of novel natural alkaloid jerantinine B